Shares of Health Managment and JAKKS Drop to Annual Low Points Today
Even though the financial markets climbed higher steadily today, these companies were battered by negative news. Consequently, shareholders saw 52-week lows for these companies:
Health Management (NYSE:HMA): The recently filed lawsuit against Health Management Associates is affecting the stock. Federal subpoenas were sent to the firm after a whistleblower alleged losing his job when he reported repeated Medicare overbilling. Susquehanna’s A.J. Rice is telling clients an “extraordinary buying opportunity” exists. The shares closed at $6.05, down $0.91 or 13.07 percent. Their 52-week trading range has been $6.06 to $11.74.
Integra Lifesciences (NASDAQ:IART): Citigroup says Friday’s sell-off of Integra LifeSciences was overdone and reiterates a Buy with a $33 target. Based on a weak fourth quarter pre-announcement Citi believes trading range should be $27 to $28. The shares closed at $23.22, down $0.68 or 2.85 percent. Their 52-week trading range has been $23.76 to $52.90.
IPC The Hospitalist (NASDAQ:IPCM): Piper Jaffray still sees growth at IPC The Hospitalist Co.’s dismissing yesterday’s sell-off after the company’s pre-announcement. The firm lowered target from $49 to $39, but maintains an Overweight. The shares closed at $30.81, up $0.2 or 0.65 percent. Their 52-week trading range has been $30.27 to $52.25.
JAKKS Pacific (NASDAQ:JAKK): JAKKS, Top U.S. toymaker and Marvel Entertainment, LLC announce an exclusive agreement allowing JAKKS to manufacture, distribute and market a of line of plush products based on the Marvel Super Hero Squad. The line will also connect online to the HeroUp.com, Marvel’s new virtual world. JAKKS Pacific also received rights for skill and action games inspired by Marvel classic characters. The shares closed at $13.38, down $0.05 or 0.37 percent. Their 52-week trading range has been $13.30 to $21.21.
Hugoton Royalty Trus (NYSE:HGT): The shares closed at $16.57, down $0.82 or 4.72 percent. Their 52-week trading range has been $17.17 to $24.67.
Further Reading: Eastman Kodak’s New Business: Suing for Dollars>>
To contact the reporter on this story: Jim Wilkerson at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com